VanEck Global Hlthcr Ldrs ETF
HLTH
- A$11.57
- 0.16
- 1.36%
VanEck Global Hlthcr Ldrs ETF HLTH Strategy
The Fund gives investors access to a portfolio of leading international developed markets companies with the best growth at a reasonable price (‘GARP’) attributes from the global health care sector.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
What Australian investors are buying and selling
The Australian ETF and managed fund landscape at the end of 2025.
etfs
Young & Invested: The currency trap catching ETF investors off guard
Why your fund’s currency exposure matters more than you think.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,297.20 | 123.30 | -1.31% |
| CAC 40 | 8,119.89 | 274.43 | -3.27% |
| DAX 40 | 23,682.98 | 955.02 | -3.88% |
| Dow JONES (US) | 48,904.78 | 73.14 | -0.15% |
| FTSE 100 | 10,473.35 | 306.76 | -2.85% |
| HKSE | 25,768.08 | 612.94 | -2.32% |
| NASDAQ | 22,748.86 | 80.64 | 0.36% |
| Nikkei 225 | 56,279.05 | 2,474.34 | -4.21% |
| NZX 50 Index | 13,620.21 | 50.50 | -0.37% |
| S&P 500 | 6,881.62 | 0.00 | 0.00% |
| S&P/ASX 200 | 9,077.30 | 104.40 | -1.14% |
| SSE Composite Index | 4,122.68 | 59.92 | -1.43% |